Lipid-Based Oral Formulation Strategies for Enhancing Bioavailability of Aromatase Inhibitors
<p id="p1">Aromatase inhibitors (AIs) are frontline agents in the hormonal treatment of estrogen receptor-positive breast cancer. However, their poor aqueous solubility, variable gastrointestinal absorption, and extensive first-pass metabolism significantly limit their oral bioavailability and thera...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2025
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/1230164 |
| Tags: |
No Tags, Be the first to tag this record!
|